Health Care & Life Sciences » Biotechnology | Skystar Bio-Pharmaceutical Co.

Skystar Bio-Pharmaceutical Co. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2009
2010
2011
2012
2013
Sales/Revenue
33,778.30
47,556.40
52,788.30
33,586.80
42,483.70
Cost of Goods Sold (COGS) incl. D&A
16,521.00
22,011.60
26,562.70
15,095.00
20,993.00
Gross Income
17,257.30
25,544.80
26,225.50
18,491.80
21,490.80
SG&A Expense
5,562.80
7,434.80
10,975.60
9,940.80
8,477.90
EBIT
11,694.50
18,110.00
15,249.90
8,551.00
13,012.90
Unusual Expense
868.40
612.90
1,376.20
37.80
56.80
Non Operating Income/Expense
117.90
49.20
43.70
498.60
48.40
Interest Expense
62.60
58.80
140.90
706.80
612.50
Pretax Income
10,881.30
17,389.00
16,528.90
8,380.60
12,931.60
Income Tax
2,029.40
3,297.80
2,871.30
2,168.10
2,401.30
Consolidated Net Income
8,851.90
14,091.30
13,657.60
6,212.40
10,530.30
Net Income
8,851.90
14,091.30
13,657.60
6,212.40
10,530.30
Net Income After Extraordinaries
8,851.90
14,091.30
13,657.60
6,212.40
10,530.30
Net Income Available to Common
8,851.90
14,091.30
13,657.60
6,212.40
10,530.30
EPS (Basic)
1.65
1.98
1.90
0.83
1.38
Basic Shares Outstanding
5,374.50
7,105.80
7,183.00
7,471.40
7,651.60
EPS (Diluted)
1.62
1.97
1.90
0.83
1.37
Diluted Shares Outstanding
5,459.50
7,138.30
7,184.50
7,471.40
7,686.30
EBITDA
12,473.50
19,380.80
17,121.70
9,987.90
14,727.00
Non-Operating Interest Income
-
-
-
-
539.60

About Skystar Bio-Pharmaceutical

View Profile
Address
4/F Building B, Chuangye Square
Xi'an Shaanxi 710000
China
Employees -
Website http://www.skystarbio-pharmaceutical.com
Updated 09/14/2018
Skystar Bio-Pharmaceutical Co. is a holding company that engages in the research, development, production, distribution, and sale of veterinary healthcare and medical care products. It operates through the following product lines: micro-organism, veterinary medicine, feed additives, and bio-pharmaceutical veterinary vaccine. The company was founded in 1997 and is headquartered in Xi'an, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.